DAVENPORT & Co LLC Has $4.07 Million Holdings in HCA Healthcare, Inc. $HCA

DAVENPORT & Co LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 20.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,543 shares of the company’s stock after selling 2,388 shares during the period. DAVENPORT & Co LLC’s holdings in HCA Healthcare were worth $4,067,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Park Place Capital Corp increased its stake in HCA Healthcare by 2,336.0% in the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of HCA Healthcare by 11.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares during the period. Swiss National Bank lifted its position in shares of HCA Healthcare by 4.3% during the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares during the period. Cherokee Insurance Co acquired a new position in HCA Healthcare during the second quarter worth $3,869,000. Finally, Harrell Investment Partners LLC boosted its stake in shares of HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent analyst reports. Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Bank of America increased their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. Jefferies Financial Group boosted their price objective on HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. Barclays lifted their price target on HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Fourteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Trading Up 0.7%

Shares of NYSE:HCA opened at $477.30 on Friday. The stock has a market capitalization of $108.92 billion, a P/E ratio of 18.45, a P/E/G ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The business has a 50-day moving average price of $475.66 and a two-hundred day moving average price of $420.04.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the previous year, the firm posted $4.90 earnings per share. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.